...
首页> 外文期刊>Dental Hypotheses >Evaluation of Platelet Rich Fibrin in the Management of Gingival Recession Type I/II by Miller: A Randomized Clinical Split Mouth Study
【24h】

Evaluation of Platelet Rich Fibrin in the Management of Gingival Recession Type I/II by Miller: A Randomized Clinical Split Mouth Study

机译:Miller评价富血小板纤维蛋白在I / II型牙龈萎缩治疗中的作用:一项随机的临床裂口研究

获取原文
           

摘要

Introduction: The ultimate goal of mucogingival plastic surgery is to obtain complete root coverage and an optimal appearance. The aim of this study was to evaluate the efficacy of platelet-rich fibrin (PRF) with coronally advanced flap (CAF) compared to connective tissue graft (CTG) with CAF in the treatment of gingival recession (GR). Material and Methods: A total of 20 patients were included in this randomized clinical study, presenting 40 GR Miller type I/II. The GR sides of patients were assigned randomly into test group (PRF?+?CAF) and control group (CTG?+?CAF). Clinical parameters, such as GR, probing depth (PD), clinical attachment level (CAL), and width of keratinized gingiva (WKG), were evaluated at baseline and 12 months later. Root coverage (RC %) and complete root coverage (CRC %) were assessed at 12 months post surgically. Statistical analysis was performed using paired, independent t-test and Mann–Whitney U test. Statistical significance was set at 0.05. Results: At 12 months the mean (SD) GR was 0.20?±?0.50?mm for test group and 0.05?±?0.15?mm for control group, whereas the mean RC% was 95.32?±?11.92 for PRF?+?CAF and 98.61?±?4.37 for CTG?+?CAF. CRC was obtained in CTG?+?CAF with 90% and with 80% in PRF?+?CAF. CAL gain was 2.80?±?0.28?mm and 2.49?±?0.55?mm in test and control sites, respectively. The gain of WKG was 1.31?±?0.45?mm and 1.85?±?0.25?mm in test and control sites, respectively. All the values were not significantly different (P ≥ 0.05). Conclusion: Using of PRF?+?CAF in the treatment of GR is a successful and effective treatment option and could serve as an alternative to CTGs.
机译:简介:粘膜龈整形手术的最终目标是获得完整的牙根覆盖和最佳的外观。这项研究的目的是评估具有冠状动脉前皮瓣(CAF)的富血小板纤维蛋白(PRF)与具有CAF的结缔组织移植物(CTG)相比在治疗牙龈退缩(GR)中的疗效。材料和方法:这项随机临床研究共纳入20例患者,表现为40例GR Miller I / II型。将患者的GR侧随机分为试验组(PRF + CAF)和对照组(CTG + CAF)。在基线时和12个月后评估了临床参数,例如GR,探测深度(PD),临床依附水平(CAL)和角化牙龈宽度(WKG)。术后12个月评估根的覆盖率(RC%)和完全的根覆盖率(CRC%)。使用配对的独立t检验和Mann-Whitney U检验进行统计分析。统计显着性设定为0.05。结果:在12个月时,试验组的平均(SD)GR为0.20≤±0.50μmm,对照组为0.05≤±0.15μmm,而PRF≥+的平均RC%为95.32±±11.92。 CAF和CTG + CAF为98.61±±4.37。在CTGβ+αCAF中获得CRC的比例为90%,在PRFβ+αCAF中为80%。在测试和对照部位的CAL增益分别为2.80±0.28mm和2.49±0.55mm。在测试和对照部位,WKG的增益分别为1.31±0.45mm和1.85±0.25mm。所有值均无显着性差异(P≥0.05)。结论:使用PRF?+?CAF治疗GR是一种成功而有效的治疗选择,可以替代CTG。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号